Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Drug Injection Devices to 2020


News provided by

Research and Markets

12 Dec, 2014, 16:26 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, Dec. 11, 2014 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/2r6bmg/drug_injection) has announced the addition of the "Drug Injection Devices to 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug designers and marketers.

The injectable device sector today consists of a half-dozen established device classes and two emerging classes. For the remainder of the decade, pipeline drugs and shifting demographics will drive sector growth as an aging population of baby boomers (23% of US population) provides stimulus for industry demand. Currently, the over 65 segment accounts for approximately 13% of the US population, with an estimated 40% of total healthcare expenditures, but by 2020, this segment is expected to grow to 17% of the population.

This aging of the population will predominately benefit products that can be used by the elderly.This report examines the key therapeutic, product, market and regulatory factors for injection devices, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

  • Analyzes and evaluates the shifting landscape for syringes and injection devices and assesses the market impact of new and evolving devices by therapeutic indication
  • Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
  • Provides detailed descriptions of key injectable device therapeutic market segments, market demographics, and business strategies
  • Forecasts syringe and injection device demand by indication and therapy to 2020
  • Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered:

  1. Executive Summary
  2. Drug Injection Device Market Dynamics
  3. Evolution in Injectable Drug Development
  4. Injectable Drug Demand Drivers
  5. Diseases and Indications
  6. Syringe Economics
  7. Chronic Conditions & Self-Administration
  8. Technology Factors
  9. Device Selection Factors
  10. Market Segmentation
  11. Product Features & Ease of Use
  12. Competitive Landscape
  13. Injection Device Suppliers
  14. Capabilities and Market Presence
  15. Technology and Infrastructure
  16. Market Success Factors
  17. Injection Devices
  18. Autoinjectors
  19. Dual Chamber Syringes
  20. Needle-free Injectors
  21. Pen Injectors
  22. Prefilled Syringes
  23. Safety Syringes
  24. Emerging Device Classes
  25. Wearable Injectors
  26. Patch Pumps
  27. Large Volume wearable Injectors
  28. Risks and Opportunities
  29. Injection Device Selection Criteria
  30. Stability and Material Selection Issues
  31. Single vs Multi-Dose Devices
  32. Fixed vs Variable Dose Devices
  33. Lyophilized Drugs/Reconstitution
  34. Syringe Safety/Sharps Protection
  35. Needle Configuration Strategies
  36. Disposable Drug Cartridges
  37. Human Engineering/Ergonomics
  38. Branding/Private Labeling
  39. Drug Delivery Devices - Device Classes and Analysis
  40. Autoinjectors
  41. Autoinjector Device Categories
  42. Reusable Autoinjectors
  43. Disposable Autoinjectors
  44. Product Specific Autoinjectors
  45. Autoinjector-specific Selection Factors
  46. Safety Features
  47. Needle Shielding
  48. Needle Insertion Depth
  49. Failsafe Activation
  50. Dose Inspection/Injection Confirmation
  51. Device Evolution and Market Impact
  52. Dual Chamber Syringes
  53. Needle-free Injectors
  54. Device Categories
  55. End User/Practitioner/Mass Immunization Injectors
  56. Prefilled Disposable Models
  57. Refillable Cartridge Designs
  58. Needle-free Injector-specific Selection Factors
  59. Energy Source/Injection Site Selection
  60. Injection Site Selection
  61. Needle-free Injectors - the Next Six Years
  62. Pen Injectors
  63. Recent Segment Evolution and Product Consolidation
  64. Pen Design and Device Selection
  65. Standardized Pen Platforms
  66. Custom Pen Designs
  67. Pen Classes
  68. Reusable Pens
  69. Disposable Pens
  70. Dual Chamber Pens
  71. Pen Injector Evolution and Growth
  72. Prefilled Syringes
  73. Prefilled Syringe Device Categories
  74. Glass Prefilled Syringes
  75. Plastic Prefilled Syringes
  76. Prefillable Safety Syringes
  77. Prefilled Syringe Selection Factors
  78. Ready to Fill Prefillable Syringes
  79. Fill-and-Finish CSO Selection
  80. PFS Trending and Evolution - the Next Six Years
  81. Safety Syringes
  82. Safety Syringe Device Categories
  83. Integrated Safety Syringes
  84. Automatic Safety Mechanism
  85. Manual Safety Mechanism
  86. Post Manufacture Add-on/Bolt-on Safety Mechanisms
  87. Safety Syringes - Market Evolution and Segment Expectations
  88. Wearable Injectors
  89. Patch Pumps
  90. Large Volume Wearable Injectors
  91. Drug Injection Device Market Segment Analysis & Forecasts
  92. Anaphylaxis
  93. Anticoagulants
  94. Antivirals
  95. Autoimmune Diseases
  96. Diabetes
  97. Emergency Medicine
  98. Hematopoietics
  99. Hormone Replacement
  100. Neurology
  101. Osteoporosis
  102. Reproductive Health
  103. Vaccines
  104. Injectable Drug Therapeutics - Market Factors
  105. Regulatory Factors and Issues
  106. FDA Regulations
  107. Regulating Combination Products
  108. Sharps Legislations
  109. Growth and Diversity of Safety Syringes
  110. Sharps Disposal
  111. Managed Care and Healthcare Economics
  112. Company Profiles

For more information visit http://www.researchandmarkets.com/research/2r6bmg/drug_injection

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.